会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Oxepin derivative
    • 奥克辛衍生物
    • US20100004456A1
    • 2010-01-07
    • US12311215
    • 2007-09-27
    • Kunihiko HigashiuraTakashi OginoKazuhito FurukawaYuriko Yamazaki
    • Kunihiko HigashiuraTakashi OginoKazuhito FurukawaYuriko Yamazaki
    • C07D405/04
    • C07D405/04
    • The present invention provides a compound, an oxepin derivative having excellent histamine receptor antagonistic action, which is useful as an antihistamine. The oxepin derivative of the present invention has a potent histamine receptor antagonistic action. Further, the compound of the present invention shows low intracerebral migration even when a mouse that is orally administered with the compound is subjected to an intracerebral receptor binding test, so that the compound has preferred properties of alleviating side effects in the central nervous system, such as drowsiness. The oxepin derivative of the present invention is very useful as a novel antihistamine having smaller side effects in the central nervous system, such as drowsiness.
    • 本发明提供一种化合物,具有优异的组胺受体拮抗作用的氧杂环丁衍生物,其可用作抗组胺药。 本发明的oxepin衍生物具有有效的组胺受体拮抗作用。 此外,本发明的化合物即使经口给予该化合物的小鼠进行脑内受体结合试验,也显示低脑内迁移,使得该化合物具有优选的减轻中枢神经系统副作用的性质,例如 作为嗜睡 本发明的oxepin衍生物作为在中枢神经系统中具有较小副作用的新型抗组胺药如睡意觉是非常有用的。
    • 3. 发明授权
    • Aminopropylidene derivative
    • 氨基亚丙基衍生物
    • US08653285B2
    • 2014-02-18
    • US13055780
    • 2009-07-31
    • Kunihiko HigashiuraTakashi OginoTaizo ItoKoji KunimasuKazuhito Furukawa
    • Kunihiko HigashiuraTakashi OginoTaizo ItoKoji KunimasuKazuhito Furukawa
    • C07D313/08C07D333/50A61K31/38A61K31/335
    • C07D495/04C07D333/78
    • An aminopropylidene derivative having excellent histamine receptor antagonistic action, a compound which is useful as a pharmaceutical composition, especially as an active ingredient, having alleviated side effects in the central nervous system is described. In the aminopropylidene derivative, R1 and R2, which may be identical or different, stand for a hydrogen, a substituted carbonyl, a substituted carbonylalkyl, and acrylic acid, excluding a case where both are hydrogen; R3 and R4, which may be identical or different, stand for hydrogen, an alkyl which may be substituted with phenyl, or the like; A stands for unsubstituted or an oxo; B stands for a carbon or an oxygen; one of X and Y stands for a carbon and the other stands for a sulfur, a broken line part stands for a single bond or a double bond, and a wavy line stands for cis-form and/or trans-form.
    • 描述了具有优异的组胺受体拮抗作用的氨基亚丙基衍生物,可用作药物组合物的化合物,特别是作为活性成分,在中枢神经系统中具有缓解的副作用。 在氨基亚丙基衍生物中,R 1和R 2可以相同或不同,代表氢,取代的羰基,取代的羰基烷基和丙烯酸,不包括两者均为氢的情况; R3和R4可以相同或不同,代表氢,可被苯基取代的烷基等; A代表未取代或氧代; B代表碳或氧; X和Y中的一个代表碳,另一个代表硫,虚线部分代表单键或双键,波浪线代表顺式和/或反式。
    • 4. 发明授权
    • Oxepin derivative
    • 奥克辛衍生物
    • US08222419B2
    • 2012-07-17
    • US12311215
    • 2007-09-27
    • Kunihiko HigashiuraTakashi OginoKazuhito FurukawaYuriko Yamazaki
    • Kunihiko HigashiuraTakashi OginoKazuhito FurukawaYuriko Yamazaki
    • C07D401/00
    • C07D405/04
    • The present invention provides a compound, an oxepin derivative having excellent histamine receptor antagonistic action, which is useful as an antihistamine. The oxepin derivative of the present invention has a potent histamine receptor antagonistic action. Further, the compound of the present invention shows low intracerebral migration even when a mouse that is orally administered with the compound is subjected to an intracerebral receptor binding test, so that the compound has preferred properties of alleviating side effects in the central nervous system, such as drowsiness. The oxepin derivative of the present invention is very useful as a novel antihistamine having smaller side effects in the central nervous system, such as drowsiness.
    • 本发明提供一种化合物,具有优异的组胺受体拮抗作用的氧杂环丁衍生物,其可用作抗组胺药。 本发明的oxepin衍生物具有有效的组胺受体拮抗作用。 此外,本发明的化合物即使经口给予该化合物的小鼠进行脑内受体结合试验,也显示低脑内迁移,使得该化合物具有优选的减轻中枢神经系统副作用的性质,例如 作为嗜睡 本发明的oxepin衍生物作为在中枢神经系统中具有较小副作用的新型抗组胺药如睡意觉是非常有用的。
    • 8. 发明授权
    • Piperidine derivative
    • 哌啶衍生物
    • US08377967B2
    • 2013-02-19
    • US12864878
    • 2008-11-20
    • Kunihiko HigashiuraTakashi OginoTaizo ItoHiroyuki Iwatsuki
    • Kunihiko HigashiuraTakashi OginoTaizo ItoHiroyuki Iwatsuki
    • A61K31/4535C07D409/02A61P37/08
    • C07D495/04C07D409/04C07D497/04
    • The present invention provides a compound a piperidine derivative having excellent histamine receptor antagonistic action, which is useful as active ingredients of a pharmaceutical composition, especially an antihistamine. The piperidine derivative of the present invention has a potent histamine receptor antagonistic action. Further, the compound of the present invention shows low brain transfer even in a cerebral receptor binding test where a mouse is orally administered with the compound, so that the compound has preferred properties of alleviating side effects in the central nervous system, such as drowsiness. The piperidine derivative of the present invention is very useful as a novel antihistamine having smaller side effects in the central nervous system, such as drowsiness.
    • 本发明提供了具有优异的组胺受体拮抗作用的化合物哌啶衍生物,其可用作药物组合物,特别是抗组胺药的活性成分。 本发明的哌啶衍生物具有有效的组胺受体拮抗作用。 此外,本发明的化合物即使在小鼠口服给药化合物的脑受体结合试验中也显示低脑转移,因此该化合物具有减轻中枢神经系统中的副作用的优选性质,例如嗜睡。 本发明的哌啶衍生物作为在中枢神经系统中具有较小副作用的新型抗组胺药例如嗜睡是非常有用的。
    • 10. 发明申请
    • PIPERIDINE DERIVATIVE
    • 哌啶衍生物
    • US20100331365A1
    • 2010-12-30
    • US12864878
    • 2008-11-20
    • Kunihiko HigashiuraTakashi OginoTaizo ItoHiroyuki Iwatsuki
    • Kunihiko HigashiuraTakashi OginoTaizo ItoHiroyuki Iwatsuki
    • A61K31/4535C07D409/02A61P37/08
    • C07D495/04C07D409/04C07D497/04
    • The present invention provides a compound a piperidine derivative having excellent histamine receptor antagonistic action, which is useful as active ingredients of a pharmaceutical composition, especially an antihistamine. The piperidine derivative of the present invention has a potent histamine receptor antagonistic action. Further, the compound of the present invention shows low brain transfer even in a cerebral receptor binding test where a mouse is orally administered with the compound, so that the compound has preferred properties of alleviating side effects in the central nervous system, such as drowsiness. The piperidine derivative of the present invention is very useful as a novel antihistamine having smaller side effects in the central nervous system, such as drowsiness.
    • 本发明提供了具有优异的组胺受体拮抗作用的化合物哌啶衍生物,其可用作药物组合物,特别是抗组胺药的活性成分。 本发明的哌啶衍生物具有有效的组胺受体拮抗作用。 此外,本发明的化合物即使在小鼠口服给药化合物的脑受体结合试验中也显示低脑转移,因此该化合物具有减轻中枢神经系统中的副作用的优选性质,例如嗜睡。 本发明的哌啶衍生物作为在中枢神经系统中具有较小副作用的新型抗组胺药例如嗜睡是非常有用的。